Back to Results
First PageMeta Content
Hypertension / Intensive care medicine / Nitrogen metabolism / Pulmonary hypertension / Nitric oxide / Neonatal intensive care unit / Medicine / Health / Chemistry


IKARIA® LAUNCHES NEXT-GENERATION DRUG-DELIVERY SYSTEM --Third-generation INOMAX DSIR Utilizes Infrared Technology -Clinton, NJ, April 11, 2011 – Ikaria, Inc., a critical care company focused on developing and commerci
Add to Reading List

Document Date: 2011-08-30 10:08:18

Open Document

File Size: 64,64 KB

Share Result on Facebook

City

Madison / Seattle / Clinton / /

Company

Ikaria Inc. / /

Country

Puerto Rico / Japan / United States / Canada / Australia / Mexico / /

Event

FDA Phase / /

Facility

Port Allen / /

IndustryTerm

drug-delivery systems / drug product / ventilation devices / treatment of hypoxic respiratory failure / manufacturing facilities / infrared technology / gas mixtures / treatment for hepatorenal syndrome / /

MedicalCondition

pulmonary blood vessels / pulmonary hypertension / airway inflammation / subsequent congestive heart failure / drug usage / hypoxic respiratory failure / Methemoglobinemia / acute myocardial infarction / /

MedicalTreatment

innovative therapies / extracorporeal membrane oxygenation / /

Organization

U.S. Food and Drug Administration / /

Person

Daniel Tassé / /

Position

Chairman and Chief Executive Officer / /

Product

INOMAX / NEXT-GENERATION DRUG / /

ProvinceOrState

New Jersey / Wisconsin / Washington / /

Technology

DRUG-DELIVERY SYSTEM / drug-delivery / Third-generation INOMAX DSIR Utilizes Infrared Technology / /

URL

www.ikaria.com / www.inomax.com / /

SocialTag